{"disease":{"id":"duodenal-neuroendocrine-tumor-g1","name":"duodenal neuroendocrine tumor g1"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02420691","title":"Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}